Shell Asset Management CO Eagle Pharmaceuticals, Inc. Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$17.74 - $31.87 $762 - $1,370	-43 Reduced 0.55%	7,809 $152,000
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $701 - $954	-28 Reduced 0.36%	7,852 $223,000
Q4 2022 Feb 07, 2023	SELL	$24.98 - $39.77 $41,866 - $66,654	-1,676 Reduced 17.54%	7,880 $230,000
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $66,182 - $118,035	-2,505 Reduced 20.77%	9,556 $252,000
Q2 2022 Aug 09, 2022	BUY	$41.26 - $51.35 $825 - $1,027	20 Added 0.17%	12,061 $536,000
Q1 2022 May 04, 2022	SELL	$44.58 - $52.6 $79,396 - $93,680	-1,781 Reduced 12.89%	12,041 $596,000
Q4 2021 Feb 09, 2022	BUY	$45.82 - $56.9 $3,253 - $4,039	71 Added 0.52%	13,822 $704,000
Q3 2021 Nov 04, 2021	SELL	$43.79 - $55.78 $25,836 - $32,910	-590 Reduced 4.11%	13,751 $767,000
Q2 2021 Aug 12, 2021	BUY	$36.86 - $44.5 $151,715 - $183,162	4,116 Added 40.25%	14,341 $614,000
Q1 2021 May 10, 2021	BUY	$40.32 - $50.97 $202,890 - $256,481	5,032 Added 96.9%	10,225 $427,000
Q2 2020 Aug 10, 2020	SELL	$43.24 - $55.02 $3,459 - $4,401	-80 Reduced 1.52%	5,193 $249,000
Q1 2020 May 11, 2020	SELL	$34.37 - $60.07 $2,818 - $4,925	-82 Reduced 1.53%	5,273 $243,000
Q4 2019 Feb 13, 2020	SELL	$54.32 - $64.31 $7,387 - $8,746	-136 Reduced 2.48%	5,355 $322,000
Q3 2019 Nov 12, 2019	SELL	$53.25 - $59.98 $2,502 - $2,819	-47 Reduced 0.85%	5,491 $311,000
Q2 2019 Aug 12, 2019	SELL	$46.61 - $58.45 $6,012 - $7,540	-129 Reduced 2.28%	5,538 $308,000
Q4 2018 Feb 13, 2019	SELL	$36.72 - $67.73 $18,360 - $33,865	-500 Reduced 8.11%	5,667 $228,000
Q2 2018 Aug 10, 2018	SELL	$51.25 - $76.62 $14,503 - $21,683	-283 Reduced 4.39%	6,167 $467,000
Q4 2017 Feb 09, 2018	SELL	$49.6 - $60.87 $202,219 - $248,166	-4,077 Reduced 38.73%	6,450 $345,000
Q3 2017 Oct 20, 2017	BUY	$46.62 - $60.36 $490,768 - $635,409	10,527	10,527 $628,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account